Papers authored by Vindrieux D

Collect these papers and discover other ones on Labmeeting. Learn more.
Emerging roles of chemokines in prostate cancer.
+ cite this
+ View Abstract
Vindrieux D, Escobar P, and Lazennec G
Endocrine-related cancer 16(3):663-73, 2009 Sep - Who cited this? | PubMed ID: 19556286 | Fulltext
Recommend
TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
+ cite this
+ View Abstract
Vindrieux D, Réveiller M, Florin A, Blanchard C, Ruffion A, Devonec M, Benahmed M, and Grataroli R
Journal of cellular physiology 206(3):709-17, 2006 Mar - Who cited this? | PubMed ID: 16245307 | Fulltext
Recommend
Characterization of tumour necrosis factor-alpha-related apoptosis-inducing ligand and its receptors in the adult human testis.
+ cite this
+ View Abstract
Grataroli R, Vindrieux D, Selva J, Felsenheld C, Ruffion A, Decaussin M, and Benahmed M
Molecular human reproduction 10(2):123, 2004 Feb - Who cited this? | PubMed ID: 14742697 | Fulltext
Recommend
Identification of tumor necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL) and its receptors in adult rat ventral prostate.
+ cite this
+ View Abstract
Vindrieux D, Devonec M, Benahmed M, and Grataroli R
Molecular and cellular endocrinology 198(1-2):115-21, 2002 Dec 30 - Who cited this? | PubMed ID: 12573821 | Fulltext
Recommend
Expression of tumor necrosis factor-alpha-related apoptosis-inducing ligand and its receptors in rat testis during development.
+ cite this
+ View Abstract
Grataroli R, Vindrieux D, Gougeon A, and Benahmed M
Biology of reproduction 66(6):1707-15, 2002 Jun - Who cited this? | PubMed ID: 12021051 | Fulltext
Recommend



Search Google Scholar for Vindrieux D

Join Labmeeting

  • Organize and search your PDF collection
  • Collect papers
  • Search millions of papers
  • Keep up to date with paper alerts
  • Read your papers from anywhere
  • Recommend papers to colleagues
  • Manage your lab
Sign Up

Join Labmeeting

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.